Vaccinations

BioNTech’s £1 billion UK investment to drive jobs, growth and medical innovation

BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.

Moderna aim to make combined flu-COVID vaccine for 2023

Speaking at the World Economic Forum, CEO Stéphane Bancel said Moderna aim to create a combined flu and COVID vaccine.

Study says breastmilk does not pass COVID to babies

Scientists say that breastfeeding will not pass COVID-19 onto a child - there was no infectious material found in the milk itself.

Study finds three doses of Pfizer vaccine can handle Omicron

New data suggests that the Pfizer and BioNTech vaccine, at three doses, is enough to stop the Omicron variant from creating severe COVID.

Vaccine passports: Reimagining their cybersecurity

Jonathan Jackson, BlackBerry, looks at how vaccine passports and digital vaccine certificates could work - while facing off with cyber-criminals across the world.

AI analyses online debate around vaccinations and climate change

Using artificial intelligence (AI), researchers analysed debates based on tweets - revealing that opinions on vaccinations are widely divided.

Over 100 Global South factories could make mRNA vaccines

Médecins Sans Frontières (MSF) found that over 100 manufacturers in Asia, Africa and Latin America are capable of making mRNA COVID vaccines - but pharmaceutical companies won't waive intellectual property rights.

Universal COVID vaccines can learn from the common cold

Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.

COVID vaccine can cause temporary change to menstruation cycle

Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.

FDA approves new long-lasting drug for HIV prevention

December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.

Shark antibody-like proteins could neutralise COVID-19 viruses

Antibody-like proteins from the immune systems of sharks could help to prepare for future coronaviruses, according to new research.

Convidecia vaccine 57.5% effective against symptomatic COVID

Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

European Commission approves Novavax COVID vaccine for use

The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.

Scientists say AstraZeneca protection decreases after three months

According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.

Study says prior infection gives 19% protection against Omicron

COVID infection previously created 85% protection against Delta - now, scientists say that this protection falls to 19% against Omicron.

What are the side effects of the Moderna booster vaccine?

Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.

Vaccinating rough sleepers with £28 million government funding

The government is aiming to vaccinate those who are homeless and sleeping rough with the Protect and Vaccinate scheme, relocating people on the street to safe accommodation over winter.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders